1. The metabolism of sulphadimethoxine (2,4-dimethoxy-6-sulphanilamidopyrimidine) was examined in nine species of primates and nine species of nonprimates. 2. The main metabolite of the drug in the urine in man, rhesus monkey, baboon, squirrel monkey, capuchin, bushbaby, slow loris and tree shrew was sulphadimethoxine N1-glucuronide. In the green monkey, although the main metabolite was N4-acetylsulphadimethoxine, the NI-glucuronide was also a major metabolite. 3. In the dog, rat, mouse, guinea pig, Indian fruit bat and hen the N I-glucuronide was a minor metabolite in the urine, whereas in the cat, ferret and rabbit this glucuronide was not found in the urine. 4. All the species examined except the dog excreted some N4-acetylsulphadimethoxine, which was the major metabolite in the green monkey, rabbit and guinea pig. 5. In the tree shrew, a doubtful primate, Nl-glucuronide formation was similar to that in the other primates. 6. It is suggested that the slow excretion of the drug by the rat may be due partly to strong binding of the drug to tissue proteins and that the strength of binding may vary with species. 7. In the rat the amount of N' -glucuronide found in the urine is not a true indication of the extent of this conjugation since much more of the conjugate was found in the bile (7 % of the dose) than in the urine (1%).
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In the rabbit, no N'-glucuronide was found in the bile or urine, but a small amount of sulphadimethoxine N4-glucuronide was found in the bile of the rat (0.5% of dose) and rabbit (0.8%).
Earlier work from this laboratory (Bridges, Kibby & Williams, 1965) indicated that in man the main metabolite of sulphadimethoxine (Madribon; 2,4-dimethoxy-6-sulphanilamidopyrimidine) in the urine was an N-glucuronide in which the glucuronyl group was attached to the sulphonamide nitrogen (N-1) of the drug. A study of the fate of the drug in several species suggested that the formation of such a glucuronide might be peculiar to man and the rhesus monkey (Bridges, Kibby, Walker & Williams, 1968) . The metabolites of the drug in urine were therefore examined in 18 species including man, eight subhuman primates and nine other animals. N' -Glucuronide excretion was detected in 15 of these species, but the N' -glucuronide was a major metabolite of the drug in urine only in the * Present address: National Cancer Institute, National Tables 1 and 2 . They were obtained mainly from dealers in the London area and were maintained on an appropriate diet. Sulphadimethoxine was taken by humans in tablet form. The subhuman primates were given the powdered drug concealed in fruit or honey. It was given by stomach tube to the other species in water or propane-1,2-diol, except the dog, which received tablets concealed in food. Cannulation of the bile duct in certain species was carried out as described by Abou-El-Makarem, Millburn, Smith & Williams (1967) . For intraperitoneal injection, the sodium salt of the drug was dissolved in water.
Determination of metabolites. Metabolites in urine were separated by paper chromatography and determined as described by Bridges et al. (1968) Table 2 shows that in man and the other primates 30-65% of the metabolites excreted in 24h consists of NI-glucuronide.
Of the non-primates three, namely the cat, ferret and rabbit, excrete no N'-glucuronide, whereas the other six eliminate less than 20% of the 24h excretion as N1-glucuronide. However, in absolute amounts, the dog, mouse and hen are excreting as much NI-glucuronide in 24h as are the green monkey, squirrel monkey and slow loris. The cat is known to have a defective glucuronic acid conjugation mechanism (see Williams, 1967) and the absence of a glucuronic acid conjugate was not unexpected.
In the carnivores, i.e. dog, cat and ferret, most of the drug is excreted unchanged (60-80% of the 24h excretion). Further, the dog, which is apparently unable to acetylate aromatic amines (see Williams, 1967) , is the only animal listed in Table 2 that does not produce N4-acetylsulphadimethoxine. In the rabbit the drug is excreted almost entirely acetylated (91% of the 24h excretion), there being no N1-glucuronide and very little (1%) unchanged drug. The drug is also highly acetylated (67%) in the guinea pig. In the primates acetylation varies widely from 2% in the capuchin monkey to 61% in the green monkey.
A perusal of Table 2 suggests that in primates, excretion is N1l-glucuronide. Biliary excretion of sulphadimethoxine. The biliary excretion of the drug after intraperitoneal injection was studied in bile-duct-cannulated rats and rabbits. Two doe rabbits injected intraperitoneally with 100mg of drug/kg excreted 2.4 and 2.6% of the dose respectively in the bile in 6h. This material consisted roughly of equal parts of free drug (0.7 % of the dose), N4-acetylsulphadimethoxine (0.9%) and sulphadimethoxine N4- glucuronide (0.8%), there being no Nl-glucuronide or N4-sulphate of the drug in the bile. Biliary excretion was also examined in nine rats. In three of these an average of 6% of the drug (100mg/kg) was excreted in the bile in 6h. In another six 10%
(range 9-12%) of the dose was excreted in 24h and 13% (range 12-16%) in 48h. The 24h bile was analysed and found to contain five metabolites, namely unchanged drug (2.3%), N4-acetylsulphadimethoxine (0.3%), Nl-glucuronide (6.8%), N4-glucuronide (0.5%) and N4-sulphate (0.1% of the dose). The main metabolite of sulphadimethoxine in bile in the rat is thus the Nl-glucuronide, and it appears that the rat is producing more of the Nl-glucuronide than is indicated by the urinary excretion, which is about 1% ( Table 2) . Distribution of 35S in the rat. The distribution of 3sS 3 days after the intraperitoneal injection of [35S]sulphadimethoxine (100mg/kg) is shown in Table 3 . Most (95%) of the 35S has been accounted for. About 62% of the dose has been eliminated, 60% in the urine and 2% in the faeces. The rest, some 30%, is still in the tissues of the animal. The plasma concentrations of 3sS after intraperitoneal injection of the drug fell slowly (see Table 4 ), for the plasma concentration of the drug at 3 days after injection was still 72% of that at 0.5h whereas at 7 days it was 24% of the 0.5h value.
DISCUSSION
Certain sulphonamide drugs have been shown to be excreted by man as stable N-glucuronides in which the glucuronyl residue is attached to the sulphonamide nitrogen (N-1) of the drug. These drugs are sulphathiazole (Uno & Ueda, 1963a) , sulphamethoxazole (Ueda & Kuribashi, 1964), sulphadimethoxine (Bridges, Kibby & Williams, 1964 , 1965 , sulphamethomidine (Bridges, Walker & Williams, 1967 and sulphadimethoxypyrimidine . Uno & Ueda (1963b) noted that the Nl-glucuronide of sulphathiazole, which occurred as a minor metabolite in human urine, did not occur in rabbit urine.
The present paper shows that 15 out of the 18 species given sulphadimethoxine orally excreted the Nl-glucuronide of the drug in the urine. No N1 -glucuronide was detected in the urine of the cat, ferret and rabbit. However, in the nine primates examined the Nl-glucuronide occurred as a major metabolite in the urine, and these nine primates include members of almost every class of primate from the tree shrew, which is regarded by some authors as a doubtful primate (see Napier & Napier, 1967) , to man (see Tables 1 and 2 ). In the non-primates the Nl-glucuronide was either a minor metabolite or did not occur at all, the main excretory products being the unchanged drug and/ or its N4-acetyl derivative. These findings suggest that Nl-glucuronide formation is a major reaction of sulphadimethoxine only in primates and that the tree shrew behaves as a primate in this respect.
Sulphadimethoxine is a drug that is rather slowly excreted in most of the species listed in Table 1 . The most rapid urinary excretion during 2 days after the dosing is found in the rabbit (75%), mouse (64%), rhesus monkey (55%) and baboon (55% of the dose). In the rat the urinary excretion of the orally administered drug is relatively slow, being only 16% in 24h and 33% in 2 days. The distribution of the 35S-labelled drug in the rat 3 days after intraperitoneal injection in dimethyl sulphoxide is shown in Table 3 . About 62% of the dose is eliminated from the body in this time, mainly in the urine (about 60%), little (2%) being found in the faeces. Nearly one-third of the dose is still in the animal. The concentration of the drug in blood, measured as 35S, also falls slowly. Other work in this laboratory has shown that sulphadimethoxine and its N4-acetyl derivative bind strongly to plasma proteins, and this suggests that the drug may bind firmly to tissue proteins, possibly more firmly in some species than others. Sulphadimethoxine N1-glucuronide, however, is poorly bound to proteins (Bridges et al. 1969) , but the formation of this conjugate in primates does not appear to affect the rate of excretion of the drug, which is more rapid in some primates than others. In fact, urinary excretion occurs most rapidly in a species, the rabbit, in which this conjugate is not found.
There is an appreciable biliary excretion of sulphadimethoxine in the rat. This amounted to about 10% of the dose in 24h and, of this, 68% (6.8% of the dose) was present as the N1-glucuronide. The amount of Nl-glucuronide found in the urine of the rat was only 1% of the dose in 24h (see Table 2 ). The rat was therefore synthesizing much more NI-glucuronide (possibly up to about 10% of the dose) than was indicated by the amount in the urine. The faecal excretion of the drug in the rat was small (about 2%; see Table 3 ), and therefore it follows that most of the drug and its metabolites excreted in the bile must have been reabsorbed from the intestine, so that an enterohepatic circulation of at least a small part of the drug could be occurring in the rat. It seems likely that the sulphadimethoxine N1-glucuronide is hydrolysed in the gut, for glucuronides are not readily absorbed as such from the intestine (see Smith & Williams, 1966) . Sulphadimethoxine N1-glucuronide (5mg/ ml), when incubated at 370C for 18h with a rat or human faecal homogenate (lml) consisting of lg of faeces suspended in 9ml of Todd-Hewitt broth, was found to be hydrolysed to the free drug. The autoclaved homogenate had no action on the glucuronide.
